Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.9 HKD | -2.27% | +4.47% | -4.33% |
30/04 | Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024 | CI |
30/04 | Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.33% | 8.5B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-3.94% | 7.26B |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Innovent Biologics : Nomura Adjusts Innovent's Price Target to HK$113.4 From HK$66.3, Keeps at Buy